Publications by authors named "David L Lewis"

Claim this Profile
D
Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease.
Christine I Wooddell, Keith Blomenkamp, Ryan M Peterson, Vladimir M Subbotin, Christian Schwabe, David L Lewis

JCI Insight· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell Carcinoma.
So C Wong, Weijun Cheng, Holly Hamilton, Anthony L Nicholas, Darren H Wakefield, David L Lewis

Mol Cancer Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.
Christine I Wooddell, Man-Fung Yuen, Henry Lik-Yuen Chan, Robert G Gish, Stephen A Locarnini, David L Lewis

Sci Transl Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers.
Thomas Schluep, Jason Lickliter, James Hamilton, David L Lewis, Ching-Lung Lai

Clin Pharmacol Drug Dev· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation-specific status of RNAi triggers in pharmacokinetic and biodistribution analyses.
Vladimir S Trubetskoy, Jacob B Griffin, Anthony L Nicholas, Eric M Nord, Zhao Xu, David L Lewis

Nucleic Acids Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities.
Robert G Gish, Bruce D Given, Ching-Lung Lai, Stephen A Locarnini, Johnson Y N Lau, David L Lewis

Antiviral Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent.
Robert G Gish, Man-Fung Yuen, Henry Lik Yuen Chan, Bruce D Given, Ching-Lung Lai, David L Lewis

Antiviral Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protease-triggered siRNA delivery vehicles.
David B Rozema, Andrei V Blokhin, Darren H Wakefield, Jonathan D Benson, Jeffrey C Carlson, David L Lewis

J Control Release· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted in vivo delivery of siRNA and an endosome-releasing agent to hepatocytes.
Magdolna G Sebestyén, So C Wong, Vladimir Trubetskoy, David L Lewis, Christine I Wooddell

Methods Mol Biol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stochasticity in natural forage production affects use of urban areas by black bears: implications to management of human-bear conflicts.
Sharon Baruch-Mordo, Kenneth R Wilson, David L Lewis, John Broderick, Julie S Mao

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection.
Christine I Wooddell, David B Rozema, Markus Hossbach, Matthias John, Holly L Hamilton, David L Lewis

Mol Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivo.
So C Wong, Jason J Klein, Holly L Hamilton, Qili Chu, Christina L Frey, David L Lewis

Nucleic Acid Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body dysmorphic disorder.
Kevin H Ende, David L Lewis, Sheldon S Kabaker

Facial Plast Surg Clin North Am· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of pathogens and irritant chemicals in land-applied sewage sludges (biosolids).
David L Lewis, David K Gattie, Marc E Novak, Susan Sanchez, Charles Pumphrey

New Solut· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.
David B Rozema, David L Lewis, Darren H Wakefield, So C Wong, Jason J Klein

Proc Natl Acad Sci U S A· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of cross-infection from upper-GI endoscopy in a hepatitis C-prevalent population.
Nabiel N Mikhail, David L Lewis, Nabiel Omar, Hossam Taha, Amal El-Badawy

Gastrointest Endosc· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do the ABCS 135 short cognitive screen and its subtests discriminate between normal cognition, mild cognitive impairment and dementia?
Timothy I M Standish, D William Molloy, Alwin Cunje, David L Lewis

Int J Geriatr Psychiatry· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPARalpha siRNA-treated expression profiles uncover the causal sufficiency network for compound-induced liver hypertrophy.
Xudong Dai, Angus T De Souza, Hongyue Dai, David L Lewis, Chang-kyu Lee

PLoS Comput Biol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress toward a nonviral gene therapy protocol for the treatment of anemia.
Magdolna G Sebestyén, Julia O Hegge, Mark A Noble, David L Lewis, Hans Herweijer

Hum Gene Ther· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic siRNA delivery via hydrodynamic intravascular injection.
David L Lewis, Jon A Wolff

Adv Drug Deliv Rev· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternate forms of logical memory and verbal fluency tasks for repeated testing in early cognitive changes.
Alwin Cunje, D William Molloy, Timothy I Standish, David L Lewis

Int Psychogeriatr· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocyte targeting of nucleic acid complexes and liposomes by a T7 phage p17 peptide.
So C Wong, Darren Wakefield, Jason Klein, Sean D Monahan, David B Rozema, David L Lewis

Mol Pharm· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice.
Angus T De Souza, Xudong Dai, Andrew G Spencer, Tom Reppen, Ann Menzie, David L Lewis

Nucleic Acids Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules.
Magdolna G Sebestyén, Vladimir G Budker, Tatiana Budker, Vladimir M Subbotin, Guofeng Zhang, David L Lewis

J Gene Med· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectopic transgene expression in butterfly imaginal wing discs using vaccinia virus.
David L Lewis, Craig R Brunetti

Biotechniques· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis